299 related articles for article (PubMed ID: 5451178)
1. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
[No Abstract] [Full Text] [Related]
2. Comparison of the combination therapy of capreomycin. Ethionamide. Cycloserine with that of kanamycin. Ethionamide. Cycloserin in the retreatment of pulmonary tuberculosis.
Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):1-13. PubMed ID: 4990959
[No Abstract] [Full Text] [Related]
3. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
[No Abstract] [Full Text] [Related]
4. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
[No Abstract] [Full Text] [Related]
5. [Effect and toxicity on the combined use of pyrazinamide, ethionamide and kanamycin in the retreatment of pulmonary tuberculosis (author's transl)].
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):199-200. PubMed ID: 555425
[No Abstract] [Full Text] [Related]
6. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
Bernard E
Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
[No Abstract] [Full Text] [Related]
7. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
Fegiz G
Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
[No Abstract] [Full Text] [Related]
8. [Actual tuberculosis therapy. An attempt to simplify and to determine a schedule of tuberculosis chemotherapy].
Virchow C
Munch Med Wochenschr; 1969 Aug; 111(35):1717-22. PubMed ID: 4309162
[No Abstract] [Full Text] [Related]
9. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
Tsukamura M
Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
[No Abstract] [Full Text] [Related]
10. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
[No Abstract] [Full Text] [Related]
11. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
[No Abstract] [Full Text] [Related]
12. Duration of application and change of a regimen with secondary drugs.
Oka S; Takase Y; Kato S
Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
[No Abstract] [Full Text] [Related]
13. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
Rizzo A; Magalhães M; Moura N
Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
[No Abstract] [Full Text] [Related]
14. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
15. [A comparison of the effects of the combined therapy with CPM+1321 TH+CS, KM+1321 TH+CS and KM+1314 TH+CS in the treatment of pulmonary tuberculosis].
Iizuka Y; Iwasaki T; Fujioka K
Kekkaku; 1969 Mar; 44(3):109-15. PubMed ID: 5783307
[No Abstract] [Full Text] [Related]
16. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
Zunić D
Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
[No Abstract] [Full Text] [Related]
17. Capreomycin-ethionamide as a retreatment regimen for pulmonary tuberculosis.
Schless JM; Allison RF; Inglis RM; Topperman S; Trapp E
Ann N Y Acad Sci; 1966 Apr; 135(2):1085-97. PubMed ID: 5328002
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
19. [Intravenous chemotherapy of pulmonary tuberculosis].
Ivaniuta OM
Vrach Delo; 1971 Jan; (1):84-7. PubMed ID: 4325153
[No Abstract] [Full Text] [Related]
20. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
